Also trades as: 0GX2.L (LSE) · $vol 0M
NRO.PA PAR
Neurones S.A.
1W: -4.9%
1M: -3.0%
3M: -2.6%
YTD: -10.1%
1Y: -12.3%
3Y: -1.5%
5Y: +10.9%
€35.20 ($39.46)
-0.65 (-1.81%)
Weekly Expected Move ±4.0%
€32
€34
€35
€37
€38
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$726M
+7.6% ▲
5Y CAGR: +7.3%
Total Liabilities
$290M
+8.7% ▲
5Y CAGR: +9.6%
Shareholders Equity
$378M
+6.7% ▲
5Y CAGR: +4.9%
Cash & Investments
$326M
+9.6% ▲
5Y CAGR: +8.4%
Total Debt
$42M
-4.5% ▼
5Y CAGR: +5.8%
Net Debt
-$284M
-12.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $143M | $265M | $272M | $298M | $326M |
| Short-Term Investments | $123M | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $267M | $265M | $272M | $298M | $326M |
| Net Receivables | $174M | $166M | $192M | $208M | $217M |
| Inventory | $1M | $887K | $353K | $709K | $267K |
| Other Current Assets | $0 | $24M | $32M | $28M | $27M |
| Total Current Assets | $449M | $464M | $507M | $546M | $588M |
| Property, Plant & Equip. | $47M | $46M | $49M | $59M | $61M |
| Goodwill & Intangibles | $44M | $46M | $46M | $53M | $58M |
| Long-Term Investments | $8M | $8M | $10M | $4M | $5M |
| Other Non-Current Assets | $0 | $0 | $0 | $7M | $7M |
| Total Non-Current Assets | $101M | $104M | $110M | $128M | $138M |
| Total Assets | $550M | $568M | $616M | $674M | $726M |
| — Liabilities — | |||||
| Accounts Payable | $33M | $38M | $43M | $44M | $58M |
| Short-Term Debt | $265K | $205K | $152K | $6M | $5M |
| Deferred Revenue | $15M | $0 | $21M | $24M | $0 |
| Other Current Liabilities | $16M | $42M | $21M | $139M | $59M |
| Total Current Liabilities | $161M | $185M | $207M | $229M | $253M |
| Long-Term Debt | $371K | $204K | $110K | $2M | $2M |
| Other Non-Current Liab. | $2M | $3M | $6M | $6M | $7M |
| Total Non-Current Liabilities | $29M | $30M | $34M | $37M | $37M |
| Total Liabilities | $191M | $215M | $241M | $266M | $290M |
| — Equity — | |||||
| Common Stock | $10M | $10M | $10M | $10M | $10M |
| Retained Earnings | $282M | $271M | $288M | $49M | $53M |
| Accumulated OCI | -$403K | $79K | $1M | $264M | $300M |
| Total Stockholders Equity | $323M | $312M | $331M | $354M | $378M |
| Total Liabilities & Equity | $550M | $568M | $616M | $674M | $726M |
| — Key Metrics — | |||||
| Total Debt | $34M | $35M | $36M | $44M | $42M |
| Net Debt | -$109M | -$230M | -$236M | -$254M | -$284M |
| Total Investments | $131M | $8M | $10M | $4M | $5M |